000 05498cam a2200433Ii 4500
988 _aSpringer_Medicine_2017
999 _c95676
_d95676
_x1
001 95676
003 ES-MaUEC
005 20230102112716.0
006 a||||fo||||\00|\0
007 cr\nn\nnnaamaa
008 170329s2017 sz a o 000 0 eng d
020 _a3319516736
_q(electronic bk.)
020 _a9783319516738
_q(electronic bk.)
020 _z3319516728
020 _z9783319516721
_q(print)
040 _aN$T
_cN$T
_dEBLCP
_dGW5XE
_dYDX
_dN$T
_dOCLCQ
_dNJR
_dUAB
_dOCLCF
_dIOG
_dCOO
_dAZU
_dUPM
_dOCLCO
_dMERER
_dESU
_dJBG
_dIAD
_dICN
_dOCLCQ
_dOCLCO
_dOTZ
_dVT2
_dOCLCO
_dOCLCQ
_dU3W
_dOCLCO
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRA401.A1
_b2017 EB
245 0 0 _aPharmaceutical policy in countries with developing healthcare systems
_cZaheer-Ud-Din Babar, editor
264 1 _aCham, Switzerland
_bAdis
_c2017
300 _a1 recurso en línea (xii, 430 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
500 _aSpringerLink
505 0 _aForeword; Preface; Contents; Chapter 1: Introduction; 1.1 Pharmaceutical Policy and€the€Right to€Health; 1.2 Pharmaceutical Production and€Supply; 1.3 Access to€Affordable Drugs; 1.4 Conclusion; References; Part I: Low and Lower Middle Income Countries; Chapter 2: Pharmaceutical Policy in€the€East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania; 2.1 Background; 2.1.1 Focus of€This Chapter; 2.1.2 Health System of€the€EAC (Health System and€Health Indicators); 2.2 Pharmaceutical Situation of€the€EAC; 2.3 EAC Medicines Policy, Legislative and€Regulatory Environment.
505 8 _a2.4 Conclusions: Summary and€Way ForwardReferences; Chapter 3: Pharmaceutical Policy in€Pakistan; 3.1 Pakistan; 3.1.1 Country Profile; 3.2 Health System of€Pakistan; 3.2.1 Health System; 3.2.2 Health Indicators; 3.3 Pharmaceutical Situation of€the€Country; 3.3.1 Pharmaceutical Industry and€Key Statistics; 3.4 Country's Regulatory Environment; 3.4.1 Medicines Regulatory Authority; 3.4.2 Quality Control; 3.4.3 Pharmacovigilance; 3.4.4 Counterfeit Medicines; 3.5 Medicines Supply System; 3.5.1 Procurement; 3.5.2 Distribution; 3.6 Medicines Financing; 3.6.1 Medicines Expenditures in€General.
505 8 _a3.6.2 Medicines Pricing3.6.3 Affordability; 3.6.4 Generic Medicines; 3.7 Medicines Use (Issues Impacting on€Rationale Medicines Use in€the€Country); 3.7.1 Medicines Use in€General (in Community Pharmacies, Dispensing Doctors and€General Hospital Sector); 3.7.2 Essential Medicine List, Selection of€Essential Medicines and€Standard Treatment Guidelines; 3.7.3 Prescribing Behaviour in€General (Factors Affecting Prescribing Behaviour); 3.7.4 Medicines' Promotional Practices; 3.7.5 The Role of€Pharmacist in€Community and€Hospital Environments.
505 8 _a3.7.6 Medicines Use Research (Including Drug Utilization Evaluation Research)3.8 Summary and€Future Direction; References; Chapter 4: Pharmaceutical Policy in€the€Philippines; 4.1 The Philippines Health System; 4.1.1 Health System of€Philippines; 4.1.2 Health Indicators; 4.2 The Philippines Pharmaceutical Sector; 4.3 Pharmaceutical Regulation in€the€Philippines; 4.3.1 Quality Control; 4.3.2 Pharmacovigilance; 4.3.3 Substandard and€Counterfeit Medicines; 4.4 Medicines Supply System in€the€Philippines; 4.4.1 The Medicines Supply System; 4.5 Medicines Financing; 4.5.1 Medicine Pricing.
505 8 _a4.5.2 Price Monitoring4.5.3 Medicines Access; 4.5.4 Medicines Access Programs of€the€DOH; 4.5.5 Industry Patient Assistance Programmes; 4.5.6 Generic Medicines; 4.6 Medicines Use; 4.6.1 Medicines Use in€General; 4.6.2 Essential Medicines and€Standard Treatment Guidelines; 4.6.3 Pharmacoeconomics; 4.6.4 Prescribing Behaviour; 4.6.5 Medicines Promotional Practices; 4.6.6 Role of€Pharmacist; 4.6.7 Pharmaceutical Care Interventions and€Assessment of€Community Pharmacy Practice; 4.6.8 Medicines Use Research; 4.7 Conclusions and€Way Forward; References; Chapter 5: Pharmaceutical Policy in€Vietnam.
520 3 _aA comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
588 0 _aOnline resource; title from PDF title page (SpringerLink, viewed April 12, 2017).
650 7 _aPolítica sanitaria
_2embne
_9405188
700 1 _aBabar, Zaheer-ud-din,
_eeditor literario
_995144
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-51673-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b09/2020
_dz
_ea
_zSI